phenylalanine and glucagon-like peptide 1

phenylalanine has been researched along with glucagon-like peptide 1 in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (33.33)29.6817
2010's5 (33.33)24.3611
2020's5 (33.33)2.80

Authors

AuthorsStudies
Hall, WL; Millward, DJ; Morgan, LM; Rogers, PJ1
Bailey, CJ; Flatt, PR; Gault, VA; Green, BD; Greer, B; Harriott, P; Irwin, N; Mooney, MH; O'Harte, FP1
Ball, AJ; Flatt, PR; McClenaghan, NH1
Clark, R; Inoue, T; Nagakura, T; Saeki, T; Shinoda, M; Sugaya, Y; Tanaka, I; Yamamoto, E; Yamazaki, K; Yasuda, N1
Duffy, NA; Flatt, PR; Gault, VA; Green, BD; Irwin, N; McKillop, AM; O'Harte, FP1
Bell, PM; Cuthbertson, J; O'Harte, FP; Patterson, S1
Eto, Y; Kawanabe, H; Kitahara, Y; Miura, K; Ogawa, S; Yasuda, R1
Chen, M; Guo, Z; Hao, J; Houze, J; Lin, DC; Lopez, E; Luo, J; Ma, Z; Nguyen, K; Rulifson, IC; Tian, B; Tian, L; Tran, T; Wang, Y; Zhang, Y1
Breitschaft, A; Darstein, C; Golor, G; Hermosillo Reséndiz, K; Hu, K1
Bojsen-Møller, KN; Dirksen, C; Holm, L; Holst, JJ; Kristiansen, VB; Madsbad, S; Madsen, JL; Martinussen, C; Rehfeld, JF; Reitelseder, S; Svane, MS; van Hall, G1
Feinle-Bisset, C; Fitzgerald, PCE; Herbillon, B; Horowitz, M; Manoliu, B; Steinert, RE1
Alaa, A; Amin, A; Frampton, J; Franco-Becker, G; Li, JV; Liu, Z; Murphy, KG; Norton, M1
Harada, K; Osuga, Y; Tsuboi, T1
Masiques, NE; Müller, M; Navarro, M; Roura, E; Tilbrook, A; van Barneveld, R; Xu, C1
Hara, H; Hira, T; Kohda, N; Noguchi, H1

Trials

5 trial(s) available for phenylalanine and glucagon-like peptide 1

ArticleYear
Physiological mechanisms mediating aspartame-induced satiety.
    Physiology & behavior, 2003, Volume: 78, Issue:4-5

    Topics: Adult; Appetite; Aspartame; Aspartic Acid; Blood Glucose; Cholecystokinin; Cross-Over Studies; Diet; Female; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Hormones; Humans; Insulin; Male; Peptide Fragments; Phenylalanine; Protein Precursors; Satiety Response; Sweetening Agents

2003
Additive hypoglycaemic effect of nateglinide and exogenous glucagon-like peptide-1 in type 2 diabetes.
    Diabetes research and clinical practice, 2011, Volume: 91, Issue:3

    Topics: Aged; Blood Glucose; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Male; Nateglinide; Phenylalanine; Postprandial Period; Treatment Outcome

2011
Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study.
    Diabetes research and clinical practice, 2014, Volume: 103, Issue:3

    Topics: Adamantane; Adolescent; Adult; Blood Glucose; Cyclohexanes; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Healthy Volunteers; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liraglutide; Male; Maximum Tolerated Dose; Metformin; Middle Aged; Nateglinide; Nitriles; Phenylalanine; Prognosis; Pyrrolidines; Somatostatin; Vildagliptin; Young Adult

2014
Effects of L-Phenylalanine on Energy Intake and Glycaemia-Impacts on Appetite Perceptions, Gastrointestinal Hormones and Gastric Emptying in Healthy Males.
    Nutrients, 2020, Jun-16, Volume: 12, Issue:6

    Topics: Appetite; Beverages; Blood Glucose; Cholecystokinin; Double-Blind Method; Energy Intake; Gastric Emptying; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Peptide YY; Phenylalanine; Young Adult

2020
Differential effects of L- and D-phenylalanine on pancreatic and gastrointestinal hormone release in humans: A randomized crossover study.
    Diabetes, obesity & metabolism, 2021, Volume: 23, Issue:1

    Topics: Appetite; Blood Glucose; Cross-Over Studies; Energy Intake; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon-Like Peptide 1; Humans; Insulin; Phenylalanine; Postprandial Period

2021

Other Studies

10 other study(ies) available for phenylalanine and glucagon-like peptide 1

ArticleYear
Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Biological chemistry, 2003, Volume: 384, Issue:12

    Topics: Adenosine Deaminase; Amino Acid Substitution; Animals; Binding, Competitive; Blood Glucose; Cell Line, Tumor; Cricetinae; Cyclic AMP; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Fibroblasts; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glutamine; Glycoproteins; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Obese; Peptide Fragments; Phenylalanine; Proline; Protein Precursors; Rats; Receptors, Glucagon; Spectrometry, Mass, Electrospray Ionization; Transformation, Genetic; Tyrosine

2003
Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide.
    The Journal of endocrinology, 2006, Volume: 190, Issue:3

    Topics: Cell Line; Colforsin; Cyclic AMP-Dependent Protein Kinases; Cyclohexanes; Dose-Response Relationship, Drug; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Nateglinide; Phenylalanine; Potassium Channels; Protein Kinase C; Stimulation, Chemical; Sulfonylurea Compounds; Tetradecanoylphorbol Acetate

2006
Effects of the combination of a dipeptidyl peptidase IV inhibitor and an insulin secretagogue on glucose and insulin levels in mice and rats.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 320, Issue:2

    Topics: Animals; Blood Glucose; Cyclohexanes; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glyburide; Imidazoles; Insulin; Male; Mice; Mice, Inbred C57BL; Nateglinide; Phenylalanine; Protease Inhibitors; Pyridazines; Rats; Rats, Wistar; Tosyl Compounds

2007
Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
    European journal of pharmacology, 2007, Jul-30, Volume: 568, Issue:1-3

    Topics: Animals; Blood Glucose; Cell Line; Cyclohexanes; Diabetes Mellitus; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Mice; Mice, Obese; Nateglinide; Peptide Fragments; Phenylalanine

2007
Nateglinide stimulates glucagon-like peptide-1 release by human intestinal L cells via a K(ATP) channel-independent mechanism.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:5

    Topics: Animals; Cell Line; Cyclohexanes; Glucagon-Like Peptide 1; Humans; Intestinal Mucosa; Intestines; Male; Nateglinide; Phenylalanine; Potassium Channels; Rats; Rats, Wistar

2011
Evaluating insulin secretagogues in a humanized mouse model with functional human islets.
    Metabolism: clinical and experimental, 2013, Volume: 62, Issue:1

    Topics: Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glyburide; Humans; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Nude; Nateglinide; Peptides; Phenylalanine; Pyrazines; Sitagliptin Phosphate; Specific Pathogen-Free Organisms; Triazoles; Venoms

2013
Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
    Gastroenterology, 2019, Volume: 156, Issue:6

    Topics: Adult; Anastomosis, Roux-en-Y; Blood Glucose; Caseins; Cholecystokinin; Cross-Sectional Studies; Dietary Proteins; Female; Gastrectomy; Gastric Bypass; Gastric Emptying; Gastrointestinal Hormones; Ghrelin; Glucagon-Like Peptide 1; Glucose; Glycerol; Humans; Insulin; Intestinal Absorption; Male; Middle Aged; Peptide YY; Phenylalanine; Postprandial Period

2019
Identification of a regulatory pathway of L-phenylalanine-induced GLP-1 secretion in the enteroendocrine L cells.
    Biochemical and biophysical research communications, 2022, 01-15, Volume: 588

    Topics: Animals; Calcium; Cell Line; Enteroendocrine Cells; Gastrointestinal Tract; Glucagon-Like Peptide 1; GTP-Binding Protein alpha Subunits, Gq-G11; Membrane Transport Proteins; Mice; Phenylalanine; Receptors, Calcium-Sensing; Receptors, G-Protein-Coupled; Sodium; Taste

2022
Leucine (and lysine) increased plasma levels of the satiety hormone cholecystokinin (CCK), and phenylalanine of the incretin glucagon-like peptide 1 (GLP-1) after oral gavages in pigs.
    Journal of animal science, 2023, Jan-03, Volume: 101

    Topics: Animals; Cholecystokinin; Glucagon-Like Peptide 1; Glucose; Incretins; Leucine; Lysine; Male; Phenylalanine; Satiation; Swine

2023
Synergistic enhancement of glucagon-like peptide-1 release by γ-aminobutyric acid and L-phenylalanine in enteroendocrine cells-searching active ingredients in a water extract of corn zein protein.
    Bioscience, biotechnology, and biochemistry, 2023, Nov-21, Volume: 87, Issue:12

    Topics: Animals; Chromatography, Liquid; Enteroendocrine Cells; gamma-Aminobutyric Acid; Glucagon-Like Peptide 1; Mice; Phenylalanine; Proteins; Tandem Mass Spectrometry; Zea mays; Zein

2023